Related Experiment Video
Updated: Feb 26, 2026

A Simple and Efficient Method for In Vivo Cardiac-specific Gene Manipulation by Intramyocardial Injection in Mice
Published on: April 16, 2018
Melatonin as a Pleiotropic Molecule with Therapeutic Potential for Type 2 Diabetes and Cancer
Marzena Wojcik1, Michal Krawczyk1, Pawel Wojcik2
1Department of Structural Biology, Faculty of Biomedical Sciences and Postgraduate Education, Medical University of Lodz, Lodz, Poland.
Background:
The incidence of both type 2 diabetes (T2DM) and cancer is increasing worldwide, making these diseases a global health problem along with increasing healthcare expenditures. The current therapeutic approaches for treating these multifactorial diseases are far from satisfactory. As increasing evidence shows beneficial effects of melatonin (MLT) on typical pathological changes occurring during the development of T2DM and cancer, the present review focuses on molecular aspects of antidiabetic and anticancer activities of MLT and, moreover, discusses several future directions of research regarding MLT application as potential therapeutic agent.
Methods:
Critical literature analysis in PubMed central combined with personal expertise.
Results:
Numerous in vitro and in vivo studies have revealed that MLT possesses a number of antidiabetic health benefits by diminishing hyperglycemia, insulin resistance, oxidative stress, and inflammation through modulating various intracellular signaling pathways or other targets involved in the pathophysiology of this disease. Mounting evidence also indicates that MLT exhibits multi-targeted anticancer effects in numerous human malignancies, mainly resulting from its ability to modulate several signal transduction pathways associated with cell survival, proliferation, and apoptosis. Furthermore, beneficial synergistic action of MLT with chemotherapy and radiotherapy has also been observed. Importantly, no adverse outcomes have been found from the clinical use of MLT, which highlights its therapeutic usefulness, either alone or in combination with other conventional therapies, in cancer treatment.
Conclusion:
The findings described in this review suggest that MLT may confer potential benefits to human health, particularly in respect to T2DM and cancer.
Insights
Melatonin (MLT) shows promise for treating type 2 diabetes and cancer by reducing hyperglycemia, insulin resistance, and tumor growth. Clinical use of MLT has demonstrated safety and potential synergistic effects with conventional therapies.
Area of Science:
- Endocrinology
- Oncology
- Molecular Biology
Background:
- Rising global incidence of type 2 diabetes (T2DM) and cancer presents significant health challenges.
- Current therapeutic strategies for T2DM and cancer are often inadequate.
- Melatonin (MLT) demonstrates potential therapeutic benefits for both conditions.
Purpose of the Study:
- To review the molecular mechanisms underlying the antidiabetic and anticancer effects of MLT.
- To explore future research directions for MLT as a therapeutic agent.
Main Methods:
- Comprehensive literature review of studies on MLT's effects.
- Analysis of in vitro and in vivo research findings.
- Incorporation of expert knowledge.
Main Results:
- MLT improves T2DM by reducing hyperglycemia, insulin resistance, oxidative stress, and inflammation.
- MLT exhibits multi-targeted anticancer effects by modulating cell survival, proliferation, and apoptosis pathways.
- MLT shows synergistic effects with chemotherapy and radiotherapy, with no reported adverse clinical outcomes.
Conclusions:
- MLT holds potential as a beneficial agent for human health, particularly in managing T2DM and cancer.
- Further research into MLT's therapeutic applications is warranted.
Related Concept Videos
Psychoneuroimmunology: Diabetes and Cancer
Management of Insomnia
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Major Hormones and Their Functions
Oxytocin, produced in the hypothalamus and released by the pituitary gland, plays a role in social bonding, childbirth, and...
Diabetes Mellitus: Type 2 and Gestational
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
